ArticleScientific reports2025
Pathology image-based predictive model for individual survival time of early-stage lung adenocarcinoma patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brief report: Artificial intelligence meets small cell lung cancer-integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tumor microenvironment (TME) is associated with tumor prognosis, immunotherapy response, and prognosis in patients. Here, we hypothesized that the entire TME in pathology image is associated with the survival time prediction. To address this hypothesis, we utilize the entire TME on pathology image of early-stage lung adenocarcinoma (esLUAD), which is the most common histological subtype of lung cancer. Notably, we investigated whether machine learning models can predict individual survival time from pathology images without region-level annotation and solely based on patient-level survival data. In particular, we proposed a pathology image-based predictive model in a cascaded learning system to predict the individual survival time of esLUAD patients in two independent cohorts (National Lung Screening Trial (NLST) and Cancer Genome Atlas Program (TCGA)). Besides that, we estimate a mean absolute error (MAE) score and a C-index score that are strongly associated with the survival time prediction. Our method achieved (361.90 MAE - 0.70 C-index) and (365.67 MAE - 0.58 C-index) in early-stage NLST and early-stage TCGA cohorts, respectively. Together, the presented results highlight the importance of computation pathology algorithms in predicting survival time using the entire TME information in pathology images and support the use of computational methods to improve the efficiency of clinical trial studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.